Cargando…

Comparison of Effects of p53 Null and Gain-of-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice

p53 is an important tumor suppressor gene which is mutated in ~50% of all human cancers. Some of these mutants appear to have acquired novel functions beyond merely losing wild-type functions. To investigate these gain-of-function effects in vivo, we generated mice of three different genotypes: MMTV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Dadi, Dumur, Catherine I., Massey, H. Davis, Ramakrishnan, Viswanathan, Subler, Mark A., Windle, Jolene J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335025/ https://www.ncbi.nlm.nih.gov/pubmed/25695772 http://dx.doi.org/10.1371/journal.pone.0118029

Ejemplares similares

The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
por: Vaughan, Catherine A., et al.
Publicado: (2021)

Gain-of-Function p53N236S Mutation Drives the Bypassing of HRas(V12)-Induced Cellular Senescence via PGC–1α
por: Yang, Hao, et al.
Publicado: (2023)

Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice
por: Fan, Tingting, et al.
Publicado: (2017)

Myc-Induced Liver Tumors in Transgenic Zebrafish Can Regress in tp53 Null Mutation
por: Sun, Lili, et al.
Publicado: (2015)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

Lactation Defect in a Widely Used MMTV-Cre Transgenic Line of Mice
por: Yuan, Taichang, et al.
Publicado: (2011)

Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice
por: Li, Yi, et al.
Publicado: (2001)

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice
por: Liu, Chien-Liang, et al.
Publicado: (2023)

p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
por: Jung, Jewon, et al.
Publicado: (2021)

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma
por: Rieke, Damian T., et al.
Publicado: (2023)

Case Report: Sequential postzygotic HRAS mutation and gains of the paternal chromosome 11 carrying the mutated allele in a patient with epidermal nevus and rhabdomyosarcoma: evidence of a multiple-hit mechanism involving HRAS in oncogenic transformation
por: Zuntini, Roberta, et al.
Publicado: (2023)

Graphical technique for identifying a monotonic variance stabilizing transformation for absolute gene intensity signals
por: Archer, Kellie J, et al.
Publicado: (2004)

Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice
por: Huang, Shixia, et al.
Publicado: (2005)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation
por: Martin, R.J., et al.
Publicado: (2017)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Restriction of MMTV by APOBEC3
por: Kraase, Martin, et al.
Publicado: (2011)

Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
por: van Rossum, Agnes GSH, et al.
Publicado: (2006)

Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation
por: Schwartz, Michal, et al.
Publicado: (2020)

Mouse Mammary Tumor Virus (MMTV) and MMTV-like Viruses: An In-depth Look at a Controversial Issue
por: Parisi, Francesca, et al.
Publicado: (2022)

Gain‐of‐function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells
por: Vaughan, Catherine A., et al.
Publicado: (2017)

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice
por: Jamerson, M H, et al.
Publicado: (2004)

Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites
por: Vaughan, Catherine A., et al.
Publicado: (2014)

Transformation by Hras(G12V) is Consistently Associated with Mutant Allele Copy Gains and is Reversed by Farnesyl Transferase Inhibition
por: Chen, Xu, et al.
Publicado: (2013)

Establishment of HRAS(G12V) Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs
por: Matsuzaki, Yuriko, et al.
Publicado: (2013)

MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma
por: Miller, Michael B., et al.
Publicado: (2016)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)

Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation
por: Zhao, Jidong, et al.
Publicado: (2021)

Mechanism of Inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARα agonist AM580
por: Lu, Yongke, et al.
Publicado: (2010)

Tissue Distribution of Mouse Mammary Tumor Virus (MMTV) Antigens and Endogenous MMTV Loci in Japanese Laboratory Mouse Strains
por: Wajjwalku, Worawidh, et al.
Publicado: (1991)

Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis
por: Zhang, J, et al.
Publicado: (2009)

MMTV-Espl1 Transgenic Mice Develop Aneuploid, Estrogen Receptor Alpha (ERα)-Positive Mammary Adenocarcinomas
por: Mukherjee, Malini, et al.
Publicado: (2013)

Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice
por: Decock, Julie, et al.
Publicado: (2015)

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

Sleeping Beauty transposon system harboring HRAS, c-Myc and shp53 induces sarcomatoid carcinomas in mouse skin
por: JUNG, SUNYOUNG, et al.
Publicado: (2013)

MMTV-related sequences in feline breast carcinomas
por: Lushnikova, Ànna A, et al.
Publicado: (2009)

Mechanism of the Exchange Reaction in HRAS from Multiscale Modeling
por: Kapoor, Abhijeet, et al.
Publicado: (2014)

In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk
por: Ma, Zhikun, et al.
Publicado: (2020)

Generation of a Novel MMTV-tTA Transgenic Mouse Strain for the Targeted Expression of Genes in the Embryonic and Postnatal Mammary Gland
por: Sakamoto, Kazuhito, et al.
Publicado: (2012)

p19( Arf) Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
por: Kelly-Spratt, Karen S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ibl4a8sitpqihuj0qr9ofrtllc